Erasca Inc (ERAS)
1.95
+0.10
(+5.41%)
USD |
NASDAQ |
May 17, 16:00
1.95
0.00 (0.00%)
After-Hours: 20:00
Erasca Total Assets (Quarterly): 370.02M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 370.02M |
| December 31, 2023 | 395.30M |
| September 30, 2023 | 419.41M |
| June 30, 2023 | 440.66M |
| March 31, 2023 | 467.54M |
| December 31, 2022 | 514.91M |
| September 30, 2022 | 446.43M |
| Date | Value |
|---|---|
| June 30, 2022 | 444.82M |
| March 31, 2022 | 475.47M |
| December 31, 2021 | 501.42M |
| September 30, 2021 | 521.95M |
| June 30, 2021 | 210.38M |
| March 31, 2021 | 224.63M |
| December 31, 2020 | 124.82M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
124.82M
Minimum
Dec 2020
521.95M
Maximum
Sep 2021
396.98M
Average
442.74M
Median
Total Assets (Quarterly) Benchmarks
| Bristol-Myers Squibb Co | 99.03B |
| Exelixis Inc | 2.804B |
| Geron Corp | 482.07M |
| Verastem Inc | 123.54M |
| Karyopharm Therapeutics Inc | 204.46M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 81.61M |
| Shareholders Equity (Quarterly) | 288.41M |